While overall sentiment is bearish on XRP right now, a new catalyst could soon change that.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
AI-driven power demand is one of my highest conviction investment themes.
CNBC's Jim Cramer says SpaceX stock could more than double on IPO day.
The next Bitcoin recovery could be coming sooner than anyone expects.
If you are wondering whether Super Micro Computer is still attractively priced or already fully valued, it helps to step back and look at what the recent share price performance and fundamentals are really telling you. The stock closed at US$41.64, with the share price falling 9.7% over the last week, rising 20.1% over the last month, and showing returns of 34.5% year to date and 0.2% over the last year, alongside a very large 3 year return and more than 10x over 5 years. Recent coverage has...
Why Tyson Foods (TSN) is back on investors’ radar Tyson Foods (TSN) has returned to the spotlight after fiscal Q2 earnings topped expectations and management raised full year operating income guidance, particularly in the Chicken segment. The stock was also added to Goldman Sachs’ US Conviction List. See our latest analysis for Tyson Foods. Even after the post earnings jump, Tyson Foods’ 1 month share price return is down 13.8% and the 90 day share price return is down 4.4%. Yet the 1 year...
Wondering if NXP Semiconductors at around US$295.96 is offering fair value or if you might be paying too much for recent excitement. The stock is up 33.7% year to date and 45.2% over the last year, even though it has fallen 7.9% in the past week and 2.5% over the past month. Recent coverage has focused on NXP Semiconductors as a key semiconductor stock, which has kept investor attention on how it is positioned compared to peers and sector trends. That mix of interest and changing sentiment...
GE Vernova has outperformed the Nasdaq recently, and analysts remain highly optimistic about the stock’s prospects.
If you are wondering whether Dow is still priced attractively after its recent run, or if the easy value has already been taken, this article breaks down what the numbers are really saying about the stock. At a last close of US$33.97, Dow has delivered a 0.7% gain over the past week, a fall of 11.8% over the past month, a 40.0% return year to date, and a 25.2% return over the past year. Taken together, these figures give mixed signals about how the market is reassessing its potential and...
Dell Technologies (DELL) is in focus after reporting historic quarterly results, with revenue and earnings far ahead of expectations, very large AI server growth, and a sharply higher full year revenue outlook. See our latest analysis for Dell Technologies. Despite a sharp pullback in the last week, with the 1 day and 7 day share price returns both down around 6%, Dell’s 30 day share price return of 65% and year to date share price return above 200% highlight powerful momentum built around...
Himax Technologies (NasdaqGS:HIMX) has had its T2000 Color ePaper Timing Controller adopted by E Ink for a new 75 inch Kaleido color ePaper platform. The controller supports large format color ePaper signage targeted at digital advertising, public information displays, and smart retail use cases. The partnership focuses on higher refresh performance and ultralow power operation for next generation color ePaper panels. Himax Technologies, a fabless semiconductor company listed on...
Explore how portfolio composition and credit exposure set these two leading funds apart for fixed-income investors seeking balance between stability and income.
Anthropic, the parent company of Claude, has confidentially filed for an initial public offering.
C3.ai, Inc. recently reported fourth-quarter and full-year 2026 results showing revenue of US$51.6 million for the quarter and US$250.27 million for the year, alongside wider net losses and loss per share compared with the prior year. At the same time, Shell announced a new multi-year expansion of its global collaboration with C3 AI to deepen the use of C3 AI Reliability and agent-based root cause analysis across more than 13,000 monitored assets, underscoring real-world industrial adoption...
Rivian is rolling out its new, lower-cost R2 truck, which is a pivotal development for the EV maker.
Every headline this week wants you to buy Zillow Group (NASDAQ:Z) on the back of an earnings beat and a fresh AI-platform pitch from CEO Jeremy Wacksman. But here is what you should actually be watching. Zillow is a leveraged bet on a housing market that the company itself, in its own forward guidance, describes ... Avoid Zillow: This Infrastructure Redirect Is a “No-Brainer” Buy as the Housing Market Stalls
CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the most shorted mid-cap and small-cap stocks to buy now. On May 27, research firm Citizens reiterated a Market Perform rating and a $60 price target on CRISPR Therapeutics AG (NASDAQ:CRSP). The stance comes on the heels of the company maintaining a positive view of in vivo editing […]
Red Cat Holdings Inc. (NASDAQ:RCAT) is one of the most shorted mid-cap and small-cap stocks to buy now. On May 27, H.C Wainwright initiated coverage of Red Cat Holdings Inc. (NASDAQ:RCAT) with a Buy rating and a $20 price target. The research firm remains bullish on the company’s long-term prospects, as it provides a full […]
Leidos Holdings (NYSE:LDOS) has delivered a new Joint Management Tool to the U.S. military and defense agencies. The tool is designed to modernize satellite communications and operational oversight for global forces. JMT is now supporting the Department of War, DISA, and U.S. Space Command with real time situational awareness and more efficient SATCOM operations. For investors watching defense technology, this update puts Leidos Holdings (NYSE:LDOS) in focus as it rolls out a material...
ImmunityBio Inc. (NASDAQ:IBRX) is one of the most shorted mid-cap and small-cap stocks to buy now. On May 19, Immunitybio Inc. (NASDAQ:IBRX) confirmed the US Food and Drug Administration accepted for review the supplemental Biologics License Application (sBLA) for ANKTIVA Plus BCG in BCG Unresponsive Non-Muscle Invasive Bladder Cancer. The supplemental BLA was accepted for […]
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the most shorted mid-cap and small-cap stocks to buy now. On May 8, Chardan reiterated Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) as a Buy but lowered its price target of the stock to $14 from $16. The price target cut is in response to Amtagvi’s launch guidance. The company delivered […]
The stock is near its 52-week high as AI chip demand continues to outpace supply.
Kratos Defense & Security Solutions (NasdaqGS:KTOS) has secured new production contracts for solid rocket motors and vector control kits. The company has also won work on missile defense ground infrastructure and was selected for German uncrewed combat aircraft efforts. Additional awards cover Asia Pacific 5G defense communications systems, widening Kratos' role in global defense projects. At a share price of $58.52, NasdaqGS:KTOS reflects a business that has already seen very large 3 year...
Marvell Technology, along with Flex, will be included in the S&P 500 starting June 22.
Boston Scientific Corporation (NYSE:BSX) is one of top cheap stocks with Strong Buy ratings on Wall Street. Boston Scientific Corporation (NYSE:BSX) received a rating update from Canaccord on June 1. The firm lowered the price target on the stock to $70 from $71, reiterating a Buy rating on the shares. Canaccord stated that it updated […]
The Walt Disney Company (NYSE:DIS) is one of top cheap stocks with Strong Buy ratings on Wall Street. The Walt Disney Company (NYSE:DIS) and Royal Philips announced on May 28 the incorporation of beloved Disney animated characters and stories directly into Philips Ambient Experience for MRI at medical facilities in 87 countries across the globe […]
Merck & Co., Inc. (NYSE:MRK) is one of the best cheap stocks to buy for beginners. Moderna, Inc. and Merck & Co., Inc. (NYSE:MRK) announced on June 1 detailed results from a planned five-year follow-up analysis of the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study evaluating intismeran autogene in combination with KEYTRUDA® in patients with high-risk melanoma following […]
Sandisk Corporation (NASDAQ:SNDK) is one of the best cheap stocks to buy for beginners. Morgan Stanley raised the price target on Sandisk Corporation (NASDAQ:SNDK) to $1,750 from $1,100 on June 3 and maintained an Overweight rating on the shares. The firm told investors that there is “no quick fix to the memory shortage” that is going […]